4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026154
Sr VP/Chief Commercial Officer disposed of 15,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2022-03-17 | Other disposition | −15,000 | $2.74 | $41,100 | 163,473 | D |
| Derivatives | |||||||
| Cearnal Martin E Sr VP/Chief Commercial Officer | 2022-03-17 | Other disposition · Options (right to buy) | −5,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…